Skip to main content

Table 2 Changes in mean (s.d.) in outcomes 3 and 12 months post-treatment

From: Opiate agonist treatment to improve health of individuals with opioid use disorder in Lebanon

 

3-month assessment (n = 75)

12-month assessment (n = 36)

Variable and group

Baseline

Post 3 months

p value

Effect size

Baseline

Post 3 months

Post 12 months

p value

Effect size

EUROHIS Quality of Life Scale (8–40) mean (s.d.)

21.82 (6.59)

24.93 (6.32)

p ≤ 0.001

Cohen’s d = 0.37

22.37 (6.22)

24.16 (5.82)

24.84 (6.92)

p = 0.05

η 2 = 0.14

Anxiety (HADS) (0–21) mean (s.d.)

9.62 (4.09)

7.29 (4.55)

p = 0.001

Cohen’s d = 0.34

9.27 (3.84)

7.18 (4.19)

6.91 (3.91)

p = 0.006

η 2 = 0.24

Depression (HADS) (0–21) mean (s.d.)

8.97 (3.56)

7.66 (3.69)

p = 0.03

Cohen’s d = 0.21

8.94 (3.58)

8.01 (3.54)

7.65 (3.82)

p = 0.19

η 2 = 0.17

  1. HADS Hospital Anxiety Depression, s.d. standard deviation, d Cohen’s d effect size, η 2 eta-squared effect size